Tcelna announced as new brand name for MS therapy Tovaxin
Tcelna announced as new brand name for MS therapy Tovaxin
Opexa Therapeutics, a biotechnology company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company is rebranding its leading MS therapy with the new name Tcelna(TM). The product, previously known as Tovaxin(R), will now be known as Tcelna as the company positions itself towards the treatment of patients with Secondary Progressive MS (SPMS).
"Opexa has worked diligently in the optimization of its overall manufacturing process and clinical development program while concentrating its efforts in the SPMS indication. The rebranding of our lead product as Tcelna encompasses these advancements and our continued dedication to make a difference in the treatment of MS," commented Neil K. Warma, President and Chief Executive Officer of Opexa.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1312
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2019 Views
-
Last post by frodo
-
- 0 Replies
- 1642 Views
-
Last post by Petr75
-
- 0 Replies
- 1111 Views
-
Last post by NHE
-
- 2 Replies
- 1717 Views
-
Last post by frodo
-
- 0 Replies
- 9182 Views
-
Last post by NHE
-
- 0 Replies
- 2323 Views
-
Last post by NHE
-
- 0 Replies
- 2356 Views
-
Last post by frodo
-
- 1 Replies
- 1694 Views
-
Last post by frodo